Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Dermoscopy is useful for diagnosing different types of hair loss.

Hair shaft changes may be linked to CCCA, but their role is unclear.

Early intervention and patient education are crucial for managing alopecia areata.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Higher inflammation markers are linked to more severe alopecia areata.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

New treatments are needed for non-scarring alopecia due to current limitations.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Young women in Jamaica often experience chronic scarring hair loss.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.